Variables | Total n = 417 | (100%) |
---|---|---|
Age in years, mean (SD) | 66.4 | (8.8) |
Sex female | 233 | (55.9%) |
Positive medical history for | ||
Malignancy | 51 | (12.2%) |
cardiovascular disease | 59 | (14.1%) |
Smoking1 | ||
No | 197 | (47.2%) |
Stopped | 87 | (20.9%) |
Active | 52 | (12.5%) |
Pre-treatment symptom treatment in weeks, mean (SD)2 | 14 | (13.7) |
Presence of systemic symptoms | 182 | (43.6%) |
(Suspected) presence of peripheral arthritis | 64 | (15.3%) |
Shoulder pain/stiffness | ||
No | 11 | (2.6%) |
Unilateral | 16 | (3.8%) |
Bilateral | 390 | (93.5%) |
Hip pain/stiffness | ||
No | 39 | (9.4%) |
Unilateral | 10 | (2.4%) |
Bilateral | 368 | (88.2%) |
Movement restriction shoulders | ||
No | 222 | (53.2%) |
Unilateral | 26 | (6.2%) |
Bilateral | 169 | (40.5%) |
Movement restriction hips | ||
No | 325 | (77.9%) |
Unilateral | 26 | (6.2%) |
Bilateral | 66 | (15.8%) |
CRP in mg/L, median (IQR)3 | 29 | (15–52.5) |
ESR in mm/h, median (IQR)4 | 37 | (26–51) |
Hb in mmol/L, median (IQR)5 | 8.2 | (7.6–8.6) |